Dietary n-3 PUFA vascular targeting and the prevention of tumor growth and age-related macular degeneration

Current Medicinal Chemistry

Volumn 16, Issue 34, 2009, Pages 4511-4526

  Serini, S ^a   Piccioni, E ^a   Calviello, G ^a  

^a CATHOLIC UNIVERSITY   (Italy)

Author keywords

Age related macular degeneration; Angiogenesis; Cancer; DHA; EPA; n 3 PUFAs

Indexed keywords

DOCOSAHEXAENOIC ACID; DOCOSAPENTAENOIC ACID; FISH OIL; ICOSAPENTAENOIC ACID; ICOSAPENTAENOIC ACID ETHYL ESTER; OMEGA 3 FATTY ACID; OMEGA 6 FATTY ACID; XANTHOPHYLL; ZEAXANTHIN;

ANTIANGIOGENIC ACTIVITY; ANTINEOPLASTIC ACTIVITY; BLOOD VESSEL REACTIVITY; BREAST CANCER; CANCER PREVENTION; CANCER RISK; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CLINICAL TRIAL; COLON CANCER; DIETARY INTAKE; DISEASE ASSOCIATION; DRUG MECHANISM; DRUG TARGETING; ENDOTHELIAL DYSFUNCTION; EXPERIMENTAL STUDY; FAT INTAKE; FIBROSARCOMA; HEAD AND NECK CANCER; HEART PROTECTION; HUMAN; IN VITRO STUDY; INFLAMMATION; MALIGNANT NEOPLASTIC DISEASE; MELANOMA; MOLECULAR MECHANICS; NEOVASCULARIZATION (PATHOLOGY); NONHUMAN; RETINA MACULA AGE RELATED DEGENERATION; REVIEW; RISK ASSESSMENT; RISK REDUCTION; SQUAMOUS CELL CARCINOMA; THROMBOSIS; TUMOR GROWTH;

ANGIOGENESIS INHIBITORS; ANIMALS; BLOOD VESSELS; DIET; FATTY ACIDS, OMEGA-3; HUMANS; MACULAR DEGENERATION; NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC; NEOVASCULARIZATION, PHYSIOLOGIC; THROMBOSIS;

EID: 72449165993     PISSN: 09298673     EISSN: None     Source Type: Journal    
DOI: 10.2174/092986709789760788     Document Type: Review

References (217)

1. De Maria, G. Omega-3. An overview. Focus on omega-3 (supplement to agroFOOD industry high tech), 2008, 19, 4-9.
2. Bang, H.O.; Dyerberg, J.; Nielsen, A.B. Plasma lipid and lipoprotein pattern in Greenlandic West-coast Eskimos. Lancet, 1971, 1, 1143-1145
3. Kromann, N.; Green, A. Epidemiological studies in the Upernavik district, Greenland. Incidence of some chronic diseases 1950-1974. Acta Med. Scand., 1980, 208, 401-406
4. Burr, M.L.; Fehily, A.M.; Gilbert, J.F.; Rogers, S.; Holliday, R.M.; Sweetnam, P.M.; Elwood, P.C.; Deadman, N.M.. Effects of changes in fat, fish, and fibre intakes on death and myocardial reinfarction: diet and reinfarction trial (DART). Lancet, 1989, 2, 757-761
5. Marchioli, R.; Barzi, F.; Bomba, E.; Chieffo, C.; Di Gregorio, D.; Di Mascio, R.; Franzosi, M.G.; Geraci, E.; Levantesi, G.; Maggioni, A.P.; Mantini, L.; Marfisi, R.M.; Mastrogiuseppe, G.; Mininni, N.; Nicolosi, G.L.; Santini, M.; Schweiger, C.; Tavazzi, L.; Tognoni, G.; Tucci, C.; Valagussa, F.; GISSI-Prevenzione Investigators. Early protection against sudden death by n-3 polyunsaturated fatty acids after myocardial infarction: time-course analysis of the results of the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico (GISSI)-Prevenzione. Circulation, 2002, 105, 1897-1903
6. Yokoyama, M.; Origasa, H.; Matsuzaki, M.; Matsuzawa, Y.; Saito, Y.; Ishikawa, Y.; Oikawa, S.; Sasaki, J.; Hishida, H.; Itakura, H.; Kita, T.; Kitabatake, A.; Nakaya, N.; Sakata, T.; Shimada, K.; Shirato, K.; Japan EPA lipid intervention study (JELIS) Investigators. Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised open-label, blinded endpoint analysis. Lancet, 2007, 369, 1090-1098
7. Mozaffarian, D. Fish, n-3 fatty acids, and cardiovascular haemodynamics. J. Cardiovasc. Med. (Hagerstown), 2007, 8, S23-6.
8. De Caterina, R.; Massaro, M. Omega-3 fatty acids and the regulation of expression of endothelial pro-atherogenic and proinflammatory genes. J. Membr. Biol., 2005, 206, 103-116 (Pubitemid 43199144)
9. Russo, G.L. Dietary n-6 and n-3 polyunsaturated fatty acids: From biochemistry to clinical implications in cardiovascular prevention. Biochem. Pharmacol., 2009, 77, 937-946
10. von Schacky, C. A review of omega-3 ethyl esters for cardiovascular prevention and treatment of increased blood triglyceride levels. Vasc. Health Risk. Manag., 2006, 2, 251-262 (Pubitemid 44275461)
11. Xiao, Y.F.; Sigg, D.C.; Leaf, A. The antiarrhythmic effect of n-3 polyunsaturated fatty acids: modulation of cardiac ion channels as a potential mechanism. J. Membr. Biol., 2005, 206, 141-154 (Pubitemid 43199147)
12. Bouzan, C.; Cohen, J.T.; Connor, W.E.; Kris-Etherton, P.M.; Gray, G.M.; König, A.; Lawrence, R.S.; Savitz, D.A.; Teutsch, S.M. A quantitative analysis of fish consumption and stroke risk. Am. J. Prev. Med., 2005, 29, 347-352 (Pubitemid 41483544)
13. http://www.issfal.org.uk/pufa-recommendations.html
14. Kakar, P.; Watson, T.; Lip, G.Y. New approaches to therapy with omega-3 fatty acids. Curr. Atheroscler. Rep., 2008, 10, 79-87.
15. James, M.J.; Proudman, S.M.; Cleland, L.G. Dietary n-3 fats as adjunctive therapy in a prototypic inflammatory disease: issues and obstacles for use in rheumatoid arthritis. Prostaglandins Leukot. Essent. Fatty Acids., 2003, 68, 399-405.
16. Calder, P.C. Polyunsaturated fatty acids, inflammatory processes and inflammatory bowel diseases. Mol. Nutr. Food Res., 2008, 52, 885-897
17. Raffaelli, L.; Serini, S.; Piccioni, E.; Manicone, P.F.; Berardi, D.; Perfetti, G.; Calviello, G. N-3 polyunsaturated fatty acid effect in periodontal disease: state of art and possible mechanisms involved. Int. J. Immunopathol. Pharmacol., 2008, 21, 261-266 (Pubitemid 351988387)
18. Calviello, G.; Serini, S.; Piccioni, E. Alzheimer's disease and n-3 polyunsaturated fatty acids: beneficial effects and possible molecular pathways involved. Curr. Signal Transduct. Ther., 2008, 3, 152-157.
19. Hodge, W.G.; Barnes, D.; Schachter, H.M.; Pan, Y.I.; Lowcock, E.C.; Zhang, L.; Sampson, M.; Morrison, A.; Tran, K.; Miguelez, M.; Lewin, G. Evidence for the effect of omega-3 fatty acids on progression of age-related macular degeneration: a systematic review. Retina, 2007, 27, 216-221 (Pubitemid 46245650)
20. Sprecher, H. New advances in fatty-acid biosynthesis. Nutrition, 1996, 12, S5-7.
21. Sprecher, H.; Luthria, D.L.; Mohammed, B.S., Baykousheva, S.P. J. Lipid Res., 1995, 36, 2471.
22. Burdge, G. Alpha-linolenic acid metabolism in men and women: nutritional and biological implications. Curr. Opin. Clin. Nutr. Metab. Care, 2004, 7, 137-144 (Pubitemid 40340675)
23. Hardy, S.C.; Kleinman, R.E. Fat and cholesterol in the diet of infants and young children: implications for growth, development, and long-term health. J. Pediatr., 1994, 125, S69-77.
24. Morris, M.C. Docosahexaenoic acid and Alzheimer disease. Arch. Neurol., 2006, 63, 1527-1528
25. Saugstad, L.F. Are neurodegenerative disorder and psychotic manifestations avoidable brain dysfunctions with adequate dietary omega-3? Nutr. Health, 2006, 18, 89-101. (Pubitemid 44018976)
26. Seppänen-Laakso, T.; Vanhanen, H.; Laakso, I.; Kohtamäki, H.; Viikari, J. Replacement of butter on bread by rapeseed oil and rapeseed oil-containing margarine: effects on plasma fatty acid composition and serum cholesterol. Br. J. Nutr., 1992, 68, 639-654 (Pubitemid 23027125)
27. Guebre-Egziabher, F.; Rabasa-Lhoret, R.; Bonnet, F.; Bastard, J.P.; Desage, M.; Skilton, M.R.; Vidal, H.; Laville, M. Nutritional intervention to reduce the n-6/n-3 fatty acid ratio increases adiponectin concentration and fatty acid oxidation in healthy subjects. Eur. J. Clin. Nutr., 2008, 62, 1287-1293
28. nd ed.; Chow, K.C., Ed.; Marcel Dekker, Inc.: New York, 2000, pp. 481-516.
29. Fallon, S.; Enig, M.G. "Tripping Lightly Down the Prostaglandin Pathways". 2001. Price-Pottenger Nutrition Foundation. Enig MG, Fallon S. Tripping Lightly Down the Prostaglandin Pathways. Available at: http://www.westonaprice.org/knowyourfats/tripping.html.
30. Simopoulos, A.P. Evolutionary aspects of diet, the omega-6/omega-3 ratio and genetic variation: nutritional implications for chronic diseases. Biomed. Pharmacother., 2006, 60, 502-507
31. Serhan, C.N.; Clish, C.B.; Brannon, J.; Colgan, S.P.; Chiang, N.; Gronert, K. Novel functional sets of lipid-derived mediators with antiinflammatory actions generated from omega-3 fatty acids via cyclooxygenase 2-nonsteroidal antiinflammatory drugs and transcellular processing. J. Exp. Med., 2000, 192, 1197-1204 (Pubitemid 30786697)
32. Hong, S.; Gronert, K.; Devchand, P.; Moussignac, R.-L.; Serhan, C.N. Novel docosatrienes and 17S-resolvins generated from docosahexaenoic acid in murine brain, human blood and glial cells: autacoids in anti-inflammation. J. Biol. Chem., 2003, 278, 14677-14687
33. Mukherjee, P.K.; Marcheselli, V.L.; Serhan, C.N.; Bazan, N.G. Neuroprotectin D1: a docosahexaenoic acid-derived docosatriene protects human retinal pigment epithelial cells from oxidative stress. Proc. Natl. Acad. Sci. U. S. A., 2004, 101, 8491-8496 (Pubitemid 38736602)
34. Mengeaud, V.; Nano, J.L.; Fournel, S.; Rampal, P. Effects of eicosapentaenoic acid, gammalinolenic acid and prostaglandin E1 on three human colon carcinoma cell lines. Prostaglandins Leukot. Essent. Fatty Acids, 1992, 47, 313-319
35. Arita, M.; Bianchini, F.; Aliberti, J.; Sher, A.; Chiang, N.; Hong, S.; Yang, R.; Petasis, N.A.; Serhan, C.N. Stereochemical assignment, antiinflammatory properties, and receptor for the omega-3 lipid mediator resolvin E1. J. Exp. Med., 2005, 201, 713-722
36. Serhan, C.N.; Chiang, N.: Endogenous pro-resolving and anti-inflammatory lipid mediators: a new pharmacologic genus. Br. J. Pharmacol., 2008, 153, S200-15.
37. Tjonahen, E.; Oh, S.F.; Siegelman, J.; Elangovan, S.; Percarpio, K.B.; Hong, S.; Arita, M.; Serhan, C.N. Resolvin E2: identification and anti-inflammatory actions: pivotal role of human 5-lipoxygenase in resolvin E series biosynthesis. Chem. Biol., 2006, 13, 1193-1202
38. Arita, M.; Clish, C.B.; Serhan, C.N. The contributions of aspirin and microbial oxygenase in the biosynthesis of anti-inflammatory resolvins: novel oxygenase products from omega-3 polyunsaturated fatty acids. Biochem. Biophys. Res. Commun., 2005, 338, 149-157
39. Serhan, C.N.; Hong, S.; Gronert, K.; Colgan, S.P.; Devchand, P.R.; Mirick, G.; Moussignac, R.L. Resolvins: a family of bioactive products of omega-3 fatty acid transformation circuits initiated by aspirin treatment that counter pro-inflammation signals. J. Exp. Med., 2002, 196, 1025-1037
40. Sun, Y.P.; Oh, S.F.; Uddin, J.; Yang, R.; Gotlinger, K.; Campbell, E.; Colgan, S.P.; Petasis, N.A.; Serhan, C.N. Resolvin D1 and its aspirin-triggered 17R epimer. Stereochemical assignments, anti-inflammatory properties, and enzymatic inactivation. J. Biol. Chem., 2007, 282, 9323-9334
41. Vanhoutte, P.M. Endothelial dysfunction. Circ. J., 2009, 73, 595-601.
42. Celermajer, D.S.; Sorensen, K.E.; Gooch, V.M.; Spiegelhalter, D.J.; Miller, O.I.; Sullivan, I.D.; Lloyd, J.K.; Deanfield, J.E. Noninvasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet, 1992, 340, 1111-1115
43. Suwaidi, J.A.; Hamasaki, S.; Higano, S.T.; Nishimura, R.A.; Holmes, D.R. Jr.; Lerman, A. Long-term follow-up of patients with mild coronary artery disease and endothelial dysfunction. Circulation, 2000, 101, 948-954 (Pubitemid 30131694)
44. Endemann, D.H.; Schiffrin, E.L. Endothelial dysfunction. J. Am. Soc. Nephrol., 2004, 15, 1983-1992
45. Schächinger, V.; Britten, M.B. and Zeiher, A.M. Prognostic impact of coronary vasodilator dysfunction on adverse long-term outcome of coronary heart disease. Circulation, 2000, 101, 1899-1906 (Pubitemid 30225269)
46. Landmesser, U.; Hornig, B.; Dexler, H. Endothelial function: a critical determinant in atherosclerosis? Circulation, 2004, 109, 27-33.
47. Feletou, M.; Tang, E.H.C.; Vanhoutte, P.M. Nitric oxide, the gatekeeper of endothelial vasomotor control. Front. Biosci., 2008, 13, 4198-4217 (Pubitemid 351611598)
48. Shimokawa, H. Primary endothelial dysfunction: Atherosclerosis. J. Mol. Cell. Cardiol., 1999, 31, 23-37.
49. Higashi, Y.; Noma, K.; Yoshizumi, M.; Kihara, Y. Endothelial function and oxidative stress in cardiovascular diseases. Circ. J., 2009, 73, 411-418
50. Tagawa, H.; Shimokawa, H.; Tagawa, T.; Kuroiwa-Matsumoto, M.; Hirooka, Y.; Takeshita, A. Long-term treatment with eicosapentaenoic acid augments both nitric oxide-mediated and non-nitric oxide-mediated endothelium-dependent forearm vasodilatation in patients with coronary artery disease. J. Cardiovasc. Pharmacol., 1999, 33, 633-640 (Pubitemid 29164828)
51. Nestel, P.; Shige, H.; Pomeroy, S.; Cehun, M.; Abbey, M.; Raederstorff, D. The n-3 fatty acids eicosapentaenoic acid and docosahexaenoic acid increase systemic arterial compliance in humans. Am. J. Clin. Nutr., 2002, 76, 326-330
52. Morgan, D.R.; Dixon, L.J.; Hanratty, C.G.; El-Sherbeeny, N.; Hamilton, P.B.; McGrath, L.T.; Leahey, W.J.; Johnston, G.D.; McVeigh, G.E. Effects of dietary omega-3 fatty acid supplementation on endothelium-dependent vasodilation in patients with chronic heart failure. Am. J. Cardiol., 2006, 97, 547-551
53. Okumura, T.; Fujioka, Y.; Morimoto, S.; Tsuboi, S.; Masai, M.; Tsujino, T.; Ohyanagi, M.; Iwasaki, T. Eicosapentaenoic acid improves endothelial function in hypertriglyceridemic subjects despite increased lipid oxidizability. Am. J. Med. Sci., 2002, 324, 247-253 (Pubitemid 35278769)
54. Lauritzen, I.; Blondeau, N.; Heurteaux, C.; Widmann, C.; Romey, G.; Lazdunski, M. Polyunsaturated fatty acids are potent neuroprotectors. EMBO J., 2000, 19, 1784-1793 (Pubitemid 30204390)
55. Blondeau, N.; Widmann, C.; Lazdunski, M.; Heurteaux, C. Polyunsaturated fatty acids induce ischemic and epileptic tolerance. Neuroscience, 2002, 109, 231-241 (Pubitemid 34098964)
56. Heurteaux, C.; Laigle, C.; Blondeau, N.; Jarretou, G.; Lazdunski, M. Alpha-linolenic acid and riluzole treatment confer cerebral protection and improve survival after focal brain ischemia. Neuroscience, 2006, 137, 241-251 (Pubitemid 43031491)
57. Armah, C.K.; Jackson, K.G.; Doman ,I.; James, L.; Cheghani, F.; Minihane, A.M. Fish oil fatty acids improve postprandial vascular reactivity in healthy men. Clin. Sci. (Lond), 2008, 114, 679-686
58. Walser, B.; Giordano, R.M.; Stebbins, C.L. Supplementation with omega-3 polyunsaturated fatty acids augments brachial artery dilation and blood flow during forearm contraction. Eur. J. Appl. Physiol., 2006, 97, 347-354
59. Wu, K.T.; Huang, C.T.; Wei, J.; Tsait, L.M.; Hsu, C.H.; Chen, Y.C.; Yangs, J.M.; Lin, C.I. Vasodilator action of docosahexaenoic acid (DHA) in human coronary arteries in vitro. Chin. J. Physiol., 2007, 50, 164-170
60. Lawson, D.L.; Mehta, J.L.; Saldeen, K.; Mehta, P.; Saldeen, T.G. Omega-3 polyunsaturated fatty acids augment endothelium-dependent vasorelaxation by enhanced release of EDRF and vasodilator prostaglandins. Eicosanoids, 1991, 4, 217-223
61. Matsumoto, T.; Nakayama, N.; Ishida, K.; Kobayashi, T.; Kamata, K. Eicosapentaenoic acid improves imbalance between vasodilator and vasoconstrictor actions of endothelium-derived factors in mesenteric arteries from rats at chronic stage of type 2 diabetes. J. Pharmacol. Exp. Ther., 2009, 329, 324-334
62. Vanhoutte, P.M.; Shimokawa, H.; Tang, E.H.; Feletou, M. Endothelial dysfunction and vascular disease. Acta Physiol. (Oxf)., 2009, 196, 193-222.
63. Vanhoutte, P.M.; Tang, E.H. Endothelium-dependent contractions: When a good guy turns bad. J. Physiol., 2008, 586, 5295-5304
64. Chen, L.Y.; Lawson, D.L.; Mehta, J.L. Reduction in human neutrophil superoxide anion generation by n-3 polyunsaturated fatty acids: role of cyclooxygenase products and endothelium-derived relaxing factor. Thromb. Res., 1994, 76, 317-322
65. Ignarro, L.J.; Byrns, R.E.; Wood, K.S. Biochemical and pharmacological properties of endothelium-derived relaxing factor and its similarity to nitric oxide radical. In Vasodilatation: Vascular Smooth Muscle, Peptides, Autonomic Nerves and Endothelium, Vanhoutte, PM, ed.; Raven Press: New York, 1988, pp. 427-436
66. Heurteaux, C.; Guy, N.; Laigle, C.; Blondeau, N.; Duprat, F.; Mazzuca, M.; Lang-Lazdunski, L.; Widmann, C.; Zanzouri, M.; Romey, G.; Lazdunski, M. TREK-1, a K(+) channel involved in neuroprotection and general anesthesia. EMBO J., 2004, 23, 2684-2695
67. + channel stimulated by arachidonic acid and polyunsaturated fatty acid. EMBO J., 1998, 17, 3297-3308
68. Garry, A.; Fromy, B.; Blondeau, N.; Henrion, D.; Brau, F.; Gounonm P.; Guy, N.; Heurteaux, C.; Lazdunski, M.; Saumet, J.L. Altered acetylcholine, bradykinin and cutaneous pressure-induced vasodilation in mice lacking the TREK1 potassium channel: the endothelial link. EMBO Rep., 2007, 8, 354-359
69. Blondeau, N.; Pétrault, O.; Manta, S.; Giordanengo, V.; Gounon, P.; Bordet, R.; Lazdunski, M.; Heurteaux, C. Polyunsaturated fatty acids are cerebral vasodilators via the TREK-1 potassium channel. Circ. Res., 2007, 101, 176-184 (Pubitemid 47196585)
70. Massaro, M.; Scoditti, E.; Carluccio, M.A.; De Caterina, R. Basic mechanisms behind the effects of n-3 fatty acids on cardiovascular disease. Prostaglandins Leukot. Essent. Fatty Acids, 2008, 79, 109-115
71. De Caterina, R.; Cybulsky, M.A.; Clinton, S.K.; Gimbrone , M.A.Jr.; Libby, P. Omega-3 fatty acids and endothelial leukocyte adhesion molecules. Prostaglandins Leukot. Essent. Fatty Acids, 1995, 52, 191-195
72. De Caterina, R.; Cybulsky, M.I.; Clinton, S.K.; Gimbrone, M.A. Jr.; Libby, P. The omega-3 fatty acid docosahexaenoate reduces cytokine-induced expression of proatherogenic and proinflammatory proteins in human endothelial cells. Arterioscler. Thromb., 1994, 14, 1829-1836 (Pubitemid 2164792)
73. Bays, H.E.; Tighe, A.P.; Sadovsky, R.; Davidson, M.H. Prescription omega-3 fatty acids and their lipid effects: physiologic mechanisms of action and clinical implications. Expert Rev. Cardiovasc. Ther., 2008, 6, 391-409.
74. Massaro, M.; Habib, A.; Lubrano, L.; Del Turco, S.; Lazzerini, G.; Bourcier, T.; Weksler, B.B.; De Caterina, R. The omega-3 fatty acid docosahex-aenoate attenuates endothelial cyclooxygenase-2 induction through both NADP(H) oxidase and PKCepsilon inhibition. Proc. Natl. Acad. Sci. U.S.A., 2006,103, 15184-15189 (Pubitemid 44583185)
75. Risau, W.; Flamme, I. Vasculogenesis. Annu. Rev. Cell. Dev. Biol., 1995, 11, 73-91.
76. Risau, W. Mechanisms of angiogenesis. Nature, 1997, 386, 671-674
77. Breier, G. Angiogenesis in embryonic development-a review. Placenta, 2000, 21, S11-5.
78. Karamysheva, A.F. Mechanisms of angiogenesis. Biochemistry (Mosc)., 2008, 73, 751-762
79. Patan, S. Vasculogenesis and angiogenesis as mechanisms of vascular network formation, growth and remodeling. J. Neuro-Oncol., 2000, 50, 1-15. (Pubitemid 32166287)
80. Allt, G.; Lawrenson, J.G. Pericytes: cell biology and pathology. Cells Tissues Organs, 2001, 169, 1-11.
81. Firth, J.A. Endothelial barriers: from hypothetical pores to membrane proteins. J. Anat., 2002, 200, 541-548
82. Weis, S.M.; Lindquist, J.N.; Barnes, L.A.; Lutu-Fuga, K.M.; Cui, J.; Wood, M.R.; Cheresh, D.A. Cooperation between VEGF and beta3 integrin during cardiac vascular development. Blood, 2007, 109, 1962-1970
83. Cheresh, D.A.; Stupack, D.G. Regulation of angiogenesis: apoptotic cues from the ECM. Oncogene, 2008, 27, 6285-6298
84. Kopp H.G.; Ramos C.A.; Rafii S. Contribution of endothelial progenitors and proangiogenic hematopoietic cells to vascularization of tumor and ischemic tissue. Curr. Opin. Hematol., 2006, 13, 175-181 (Pubitemid 43755858)
85. Bonnet, C.S.; Walsh, D.A. Osteoarthritis, angiogenesis and inflammation. Rheumatology (Oxford), 2005, 44, 7-16.
86. Walsh, D.A. Angiogenesis and arthritis. Rheumatology, 1999, 38, 103-112
87. Liekens, S.; De Clercq, E.; Neyts, J. Angiogenesis: regulators and clinical applications. Biochem. Pharmacol., 2001, 61, 253-270
88. Koch, A.E. Review: angiogenesis: implications for rheumatoid arthritis. Arthritis. Rheum., 1998, 41, 951-962
89. Arenberg, D.A.; Strieter, R.M. Angiogenesis. In Inflammation: Basic Principles and Clinical Correlates; Gallin JI, Synderman R, eds.; Lippincott Williams & Wilkins: Philadelphia, 1999, pp. 851-863
90. Astrof, S.; Hynes, R.O. Fibronectins in vascular morphogenesis. Angiogenesis, 2009, 12, 165-175
91. Hynes, R.O. Cell-matrix adhesion in vascular development. J. Thromb. Haemost., 2007, 5, 32-40.
92. Madri, J.A. Extracellular matrix modulation of vascular cell behaviour. Transpl. Immunol., 1997, 5, 179-183 (Pubitemid 27489248)
93. Mundel, T.M.; Yliniemi, A.M.; Maeshima, Y.; Sugimoto, H.; Kieran, M.; Kalluri, R. Type IV collagen alpha6 chain-derived noncollagenous domain 1 (alpha6(IV)NC1) inhibits angiogenesis and tumor growth. Int. J. Cancer, 2008, 122, 1738-1744
94. Patarroyo, M.; Tryggvason, K.; Virtanen, I. Laminin isoforms in tumor invasion, angiogenesis and metastasis. Semin. Cancer Biol., 2002, 12, 197-207. (Pubitemid 34833063)
95. Onguchi, T.; Han, K.Y.; Chang, J.H.; Azar, D.T. Membrane type-1 matrix metalloproteinase potentiates basic fibroblast growth factor-induced corneal neovascularization. Am. J. Pathol., 2009, 174, 1564-1571
96. Rundhaug, J.E. Matrix metalloproteinases and angiogenesis. J. Cell Mol. Med., 2005, 9, 267-285
97. Arroyo, A.G.; Genís, L.; Gonzalo, P.; Matías-Román, S.; Pollán, A.; Gálvez, B.G. Matrix metalloproteinases: new routes to the use of MT1-MMP as a therapeutic target in angiogenesis-related disease. Curr. Pharm. Des., 2007, 13, 1787-1802
98. Stefansson, S.; Petitclerc, E.; Wong, M.K.; McMahon, G.A.; Brooks, P.C.; Lawrence, D.A. Inhibition of angiogenesis in vivo by plasminogen activator inhibitor-1. J. Biol. Chem., 2001, 276, 8135-8141 (Pubitemid 37385618)
99. Cao, Y. Positive and negative modulation of angiogenesis by VEGFR1 ligands. Sci. Signal., 2009, 2, re1.
100. Cébe-Suarez, S.; Zehnder-Fjällman, A.; Ballmer-Hofer, K. The role of VEGF receptors in angiogenesis; complex partnerships. Cell. Mol. Life Sci., 2006, 63, 601-615
101. Murakami, M.; Elfenbein, A.; Simons, M. Non-canonical fibroblast growth factor signalling in angiogenesis. Cardiovasc. Res., 2008, 78, 223-231 (Pubitemid 351556091)
102. Mumm, J.S.; Kopan, R. Notch signaling: from the outside in. Dev. Biol., 2000, 228, 151-165
103. Thurston, G.; Kitajewski, J. VEGF and Delta-Notch: interacting signalling pathways in tumour angiogenesis. Br. J. Cancer, 2008, 99, 1204-1209
104. Kuijper, S.; Turner, C.J.; Adams, R.H. Regulation of angiogenesis by Eph-ephrin interactions. Trends Cardiovasc. Med., 2007, 17, 145-151
105. Brantley-Sieders, D.; Schmidt, S.; Parker, M.; Chen, J. Eph receptor tyrosine kinases in tumor and tumor microenvironment. Curr. Pharm. Des., 2004, 10, 3431-3442 (Pubitemid 39276627)
106. Ghersi, G. Roles of molecules involved in epithelial/mesenchymal transition during angiogenesis. Front. Biosci., 2008, 13, 2335-2355 (Pubitemid 351606111)
107. Silva, R.; D'Amico, G.; Hodivala-Dilke, K.M.; Reynolds, L.E. Integrins: the keys to unlocking angiogenesis. Arterioscler. Thromb. Vasc. Biol., 2008, 28, 1703-1713
108. Zachary, I. VEGF signalling: integration and multi-tasking in endothelial cell biology. Biochem. Soc. Trans., 2003, 31, 1171-1177 (Pubitemid 38030933)
109. Komatsu, M.; Ruoslahti, E. R-Ras is a global regulator of vascular regeneration that suppresses intimal hyperplasia and tumor angiogenesis. Nat. Med., 2005, 11, 1346-1350 (Pubitemid 41752916)
110. Rankin, E.B.; Giaccia, A.J. The role of hypoxia-inducible factors in tumorigenesis. Cell Death Differ., 2008, 15, 678-685
111. Kim, H.J.; Chung, H.; Yoo, Y.G.; Kim, H.; Lee, J.Y.; Lee, M.O.; Kong, G. Inhibitor of DNA binding 1 activates vascular endothelial growth factor through enhancing the stability and activity of hypoxia-inducible factor-1alpha. Mol. Cancer Res., 2007, 5, 321-329 (Pubitemid 46706994)
112. Yu, H.G.; Zhong, X.; Yang, Y.N.; Luo, H.S.; Yu, J.P.; Meier, J.J.; Schrader, H.; Bastian, A.; Schmidt, W.E.; Schmitz, F. Increased expression of nuclear factor-kappaB/RelA is correlated with tumor angiogenesis in human colorectal cancer. Int. J. Colorectal Dis., 2004, 19, 18-22. (Pubitemid 38088281)
113. Pollet, I.; Opina, C.J.; Zimmerman, C.; Leong, K.G.; Wong, F.; Karsan, A. Bacterial lipopolysaccharide directly induces angiogenesis through TRAF6-mediated activation of NF-kappaB and c-Jun N-terminal kinase. Blood, 2003, 102, 1740-1742 (Pubitemid 37022568)
114. Sethi, G.; Sung, B.; Aggarwal, B.B. Nuclear factor-kappaB activation: from bench to bedside. Exp. Biol. Med. (Maywood), 2008, 233, 21-31.
115. Cantile, M.; Schiavo, G.; Terracciano, L.; Cillo, C. Homeobox genes in normal and abnormal vasculogenesis. Nutr. Metab. Cardiovasc. Dis., 2008, 18, 651-658
116. Shawber, C.J.; Funahashi, Y.; Francisco, E.; Vorontchikhina, M.; Kitamura, Y.; Stowell, S.A.; Borisenko, V.; Feirt, N.; Podgrabinska, S.; Shiraishi, K.; Chawengsaksophak, K.; Rossant, J.; Accili, D.; Skobe, M.; Kitajewski, J. Notch alters VEGF responsiveness in human and murine endothelial cells by direct regulation of VEGFR-3 expression. J. Clin. Invest., 2007, 117, 3369-3382 (Pubitemid 350096993)
117. Inuzuka, T.; Tsuda, M.; Kawaguchi, H.; Ohba, Y. Transcription factor 8 activates R-Ras to regulate angiogenesis. Biochem. Biophys. Res. Commun., 2009, 379, 510-513
118. Folkman, J. Angiogenesis. Annu. Rev. Med., 2006, 57, 1-18.
119. Marti, H.H.; Risau, W. Angiogenesis in ischemic disease. Thromb. Haemost., 1999, 82, 44-52.
120. Hanahan, D.; Folkman, J. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell, 1996, 86, 353-364
121. Folkman, J.; Watson, K.; Ingber, D.; Hanahan, D. Induction of angiogenesis during the transition from hyperplasia to neoplasia. Nature, 1989, 339, 58-61. (Pubitemid 19115892)
122. Gimbrone, M.A. Jr.; Cotran, R.S.; Leapman, S.B.; Folkman, J. Tumor dormancy in vivo by prevention of neovascularization. J. Exp. Med., 1972, 136, 261-276
123. Menakuru, S.R.; Brown, N.J.; Staton, C.A.; Reed, M.W. Angiogenesis in pre-malignant conditions. Br. J. Cancer, 2008, 99, 1961-1966
124. Albini, A.; Noonan, D.M.; Ferrari, N. Molecular pathways for cancer angioprevention. Clin. Cancer Res., 2007, 13, 4320-4325
125. Ferguson, T.A.; Apte, R.S. Angiogenesis in eye disease: immunity gained or immunity lost? Semin. Immunopathol., 2008, 30, 111-119
126. Sha, G.; Wu, D.; Zhang, L.; Chen, X.; Lei, M.; Sun, H.; Lin, S.; Lang, J. Differentially expressed genes in human endometrial endothelial cells derived from eutopic endometrium of patients with endometriosis compared with those from patients without endometriosis. Hum. Reprod., 2007, 22, 3159-3169 (Pubitemid 351696770)
127. Andreoli, C.M.; Miller, J.W. Anti-vascular endothelial growth factor therapy for ocular neovascular disease. Curr. Opin. Ophthalmol., 2007, 18, 502-508 (Pubitemid 351339405)
128. Kanayasu, T.; Morita, I.; Nakao-Hayashi, J.; Asuwa, N.; Fujisawa, C.; Ishii, T.; Ito, H.; Murota, S. Eicosapentaenoic acid inhibits tube formation of vascular endothelial cells in vitro. Lipids, 1991, 26, 271-276
129. Form, D.M.; Auerbach, R. PGE2 and angiogenesis. Proc. Soc. Exp. Biol. Med., 1983, 172, 214-218
130. McCarty, M.F. Fish oil may impede tumour angiogenesis and invasiveness by down-regulating protein kinase C and modulating eicosanoid production. Med. Hypotheses, 1996, 46, 107-115
131. Rose, D.P. Dietary Fat, Fatty Acids and Breast Cancer. Breast Cancer, 1997, 4, 7-16.
132. Murota, S.I.; Onodera, M.; Morita, I. Regulation of angiogenesis by controlling VEGF receptor. Ann. N. Y. Acad. Sci., 2000, 902, 208-212 (Pubitemid 30389125)
133. Yang, S.P.; Morita, I.; Murota, S.I. Eicosapentaenoic acid attenuates vascular endothelial growth factor-induced proliferation via inhibiting Flk-1 receptor expression in bovine carotid artery endothelial cells. J. Cell. Physiol., 1998, 176, 342-349
134. Kimura, Y. Carp oil or oleic acid, but not linoleic acid or linolenic acid, inhibits tumor growth and metastasis in Lewis lung carcinoma-bearing mice. J. Nutr., 2002, 132, 2069-2075 (Pubitemid 34742902)
135. Tsuji, M.; Murota, S.I.; Morita, I. Docosapentaenoic acid (22:5, n-3) suppressed tube-forming activity in endothelial cells induced by vascular endothelial growth factor. Prostaglandins Leukot. Essent. Fatty Acids, 2003, 68, 337-342 (Pubitemid 36535259)
136. Szymczak, M.; Murray, M.; Petrovic, N. Modulation of angiogenesis by omega-3 polyunsaturated fatty acids is mediated by cyclooxygenases. Blood, 2008, 111, 3514-3521
137. Calviello, G.; Serini, S.; Palozza, P. n-3 polyunsaturated fatty acids as signal transduction modulators and therapeutical agents in cancer. Curr. Signal Transduct. Ther., 2006, 1, 255-271
138. Hardman, W.E. (n-3) fatty acids and cancer therapy. J. Nutr., 2004, 134, 3427S-3430S.
139. Rose, D.P.; Connolly, J.M. Antiangiogenicity of docosahexaenoic acid and its role in the suppression of breast cancer cell growth in nude mice. Int. J. Oncol., 1999, 15, 1011-1015
140. Mukutmoni-Norris, M.; Hubbard, N.E.; Erickson, K.L. Modulation of murine mammary tumor vasculature by dietary n-3 fatty acids in fish oil. Cancer Lett., 2000, 150, 101-109
141. Tevar, R.; Jho, D.H.; Babcock, T.; Helton, W.S.; Espat, N.J. Omega-3 fatty acid supplementation reduces tumor growth and vascular endothelial growth factor expression in a model of progressive non-metastasizing malignancy. JPEN J. Parenter. Enteral. Nutr., 2002, 26, 285-289
142. Wen, B.; Deutsch, E.; Opolon, P.; Auperin, A.; Frascogna, V.; Connault, E.; Bourhis, J. n-3 polyunsaturated fatty acids decrease mucosal/epidermal reactions and enhance antitumour effect of ionising radiation with inhibition of tumour angiogenesis. Br. J. Cancer, 2003, 89, 1102-1107
143. Hardman, W.E.; Sun, L.; Short, N.; Cameron, I.L. Dietary omega-3 fatty acids and ionizing irradiation on human breast cancer xenograft growth and angiogenesis. Cancer Cell Int., 2005, 5, 12.
144. Calviello, G.; Di Nicuolo, F.; Gragnoli, S.; Piccioni, E.; Serini, S.; Maggiano, N.; Tringali, G.; Navarra, P.; Ranelletti, F.O.; Palozza, P. n-3 PUFAs reduce VEGF expression in human colon cancer cells modulating the COX-2/PGE2 induced ERK-1 and -2 and HIF-1alpha induction pathway. Carcinogenesis, 2004, 25, 2303-2310
145. Fukuda,R.; Kelly, B.; Semenza, G.L. Vascular endothelial growth factor gene expression in colon cancer cells exposed to prostaglandin E2 is mediated by hypoxia-inducible factor 1. Cancer Res., 2003, 63, 2330-2334 (Pubitemid 36538645)
146. Jung,Y.D.; Nakano, K.; Liu, W.; Gallick, G.E.; Ellis, L.M. Extracellular signal-regulated kinase activation is required for upregulation of vascular endothelial growth factor by serum starvation in human colon carcinoma cells. Cancer Res., 1999, 59, 4804-4807
147. Semenza, G.L. HIF-1 and tumor progression: pathophysiology and degeneration: AREDS report no. 23. Arch. Ophthalmol., 2008, 126, 1274-1279
148. Easwaran, V.; Lee, S.H.; Inge, L.; Guo, L.; Goldbeck, C.; Garrett, E.; Wiesmann, M.; Garcia, P.D.; Fuller, J.H.; Chan, V.; Randazzo, F.; Gundel, R.; Warren, R.S.; Escobedo, J.; Aukerman, S.L.; Taylor, R.N.; Fantl, W.J. β-Catenin regulates vascular endothelial growth factor expression in colon cancer. Cancer Res., 2003, 63, 3145-3153
149. Calviello, G.; Resci, F.; Serini, S.; Piccioni, E.; Toesca, A.; Boninsegna, A.; Monego, G.; Ranelletti, F.O.; Palozza, P. Docosahexaenoic acid induces proteasome-dependent degradation of betacatenin, down-regulation of survivin and apoptosis in human colorectal cancer cells not expressing COX-2. Carcinogenesis, 2007, 28, 1202-1209
150. Mori, H.; Yamada, Y.; Kuno, T.; Hirose, Y. Aberrant crypt foci and beta-catenin accumulated crypts; significance and roles for colorectal carcinogenesis. Mutat. Res., 2004, 566, 191-208. (Pubitemid 38472027)
151. Sheehan, K.M.; O'Connell, F.; O'Grady, A.; Conroy, R.M.; Leader, M.B.; Byrne, M.F.; Murray, F.E.; Kay, E.W. The relationship between cyclooxygenase-2 expression and characteristics of malignant transformation in human colorectal adenomas. Eur. J. Gastroenterol. Hepatol., 2004, 16, 619-625
152. Swanson, J.E.; Black, J.M.; Kinsella, J.E. Dietary menhaden oil: effects on the rate and magnitude of modification of phospholipid fatty acid composition of mouse heart and brain. Br. J. Nutr., 1988, 59, 535-545
153. Calviello, G.; Palozza, P.; Franceschelli, P.; Bartoli, G.M. Low dose eicosapentaenoic or docosahexaenoic acid administration modifies fatty acid composition and does not affect susceptibility to oxidative stress in rat erythrocytes and tissues. Lipids, 1997, 32, 1075-1083
154. Takahashi, Y.; Kitaday, Y.; Bucana, C.D.; Cleary, K.R.; Ellis, L.M. Expression of vascular endothelial growth factor and its receptor, KDR, correlates with vascularity, metastasis and proliferation of human colon cancer. Cancer Res., 1995, 55, 3964-3968
155. Mannini, A.; Kerstin, N.; Calorini, L.; Mugnai, G.; Ruggieri, S. An enhanced apoptosis and a reduced angiogenesis are associated with the inhibition of lung colonisation in animals fed an n-3 polyunsaturated fatty acid-rich diet injected with a highly metastatic murine melanoma line. Br. J. Nutr., 2009, 101, 688-693
156. Kimura, Y.; Sumiyoshi, M. Antitumor and antimetastatic actions of eicosapentaenoic acid ethylester and its by-products formed during accelerated stability testing. Cancer Sci., 2005, 96, 441-450
157. Tsuzuki, T.; Shibata, A.; Kawakami, Y.; Nakagaya, K.; Miyazawa, T. Anti-angiogenic effects of conjugated docosahexaenoic acid in vitro and in vivo. Biosci. Biotechnol. Biochem., 2007, 71, 1902-1910 (Pubitemid 350113151)
158. Tsuzuki, T.; Shibata, A.; Kawakami, Y.; Nakagawa, K.; Miyazawa, T. Conjugated eicosapentaenoic acid inhibits vascular endothelial growth factor-induced angiogenesis by suppressing the migration of human umbilical vein endothelial cells. J. Nutr., 2007, 137, 641-646 (Pubitemid 46397496)
159. Tsuzuki, T.; Igarashi, M.; Miyazawa, T. Conjugated eicosapentaenoic acid (EPA) inhibits transplanted tumor growth via membrane lipid peroxidation in nude mice. J. Nutr., 2004, 134, 1162-1166 (Pubitemid 38619957)
160. Narayanan, B.A.; Narayanan, N.K.; Simi, B.; Reddy, B.S. Modulation of inducible nitric oxide synthase and related proinflammatory genes by the omega-3 fatty acid docosahexaenoic acid in human colon cancer cells. Cancer Res., 2003, 63, 972-979
161. Hites, R.A.; Foran, J.A.; Schwager, S.J.; Knuth, B.A.; Hamilton, M.C.; Carpenter, D.O. Global assessment of polybrominated diphenyl ethers in farmed and wild salmon. Environ. Sci. Technol., 2004, 38, 4945-4949 (Pubitemid 39332021)
162. Sijtsma, L.; de Swaaf, M.E. Biotechnological production and applications of the omega-3 polyunsaturated fatty acid docosahexaenoic acid. Appl. Microbiol. Biotechnol., 2004, 64, 146-153 (Pubitemid 38553682)
163. Pulz, O.; Gross, W. Valuable products from biotechnology of microalgae. Appl. Microbiol. Biotechnol., 2004, 65, 635-648
164. Calviello, G.; Serini, S.; Piccioni, E.; Pessina, G. Antineoplastic effects of n-3 polyunsaturated fatty acids in combination with drugs and radiotherapy: preventive and therapeutic strategies. Nutr. Cancer, 2009, 61, 287-301.
165. Serini, S.; Piccioni, E.; Rinaldi, C.; Mostra, D.; Damiani, G.; Calviello, G. Fishes from an artificial lake: n-3 PUFA content and chemical-physical and ecological features of the lake. J. Food Compos Anal, 2009 (in press).
166. Makrides, M.; Neumann, M.A.; Byard, R.W.; Simmer, K.; Gibson, R.A. Fatty acid composition of the brain, retina and erythrocytes in breast- and formula-fed infants. Am. J. Clin. Nutr., 1994, 60, 189-194
167. Brenna, J.T.; Diau, G.Y. The influence of dietary docosahexaenoic acid and arachidonic acid on central nervous system polyunsaturated fatty acid composition. Prostaglandins Leukot. Essent. Fatty Acids, 2007, 77, 247-250
168. Uauy, R.; Hoffman, D.R.; Peirano, P.; Birch, D.G.; Birch, E.E. Essential fatty acids in visual and brain development. Lipids, 2001, 36, 885-895 (Pubitemid 33065189)
169. SanGiovanni, J.P.; Chew, E.Y. The role of omega-3 long-chain polyunsaturated fatty acids in health and disease of the retina. Prog. Retin. Eye Res., 2005, 24, 87-138. (Pubitemid 39535157)
170. Fliesler, S.J.; Anderson, R.E. Chemistry and metabolism of lipids in the vertebrate retina. Prog. Lipid Res., 1983, 22, 79-131.
171. Bazan, N.G.; Reddy, T.S.; Bazan, H.E.; Birkle, D.L. Metabolism of arachidonic and docosahexaenoic acids in the retina. Prog. Lipid Res., 1986, 25, 595-606.
172. Rotstein, N.P.; Aveldaño, M.I.; Barrantes, F.J.; Politi, L.E. Docosahexaenoic acid is required for the survival of rat retinal photoreceptors in vitro. J. Neurochem., 1996, 66, 1851-1859 (Pubitemid 26118772)
173. Rotstein, N.P.; Aveldaño, M.I.; Barrantes, F.J.; Roccamo, A.M.; Politi, L.E. Apoptosis of retinal photoreceptors during development in vitro: protective effect of docosahexaenoic acid. J. Neurochem., 1997, 69, 504-513 (Pubitemid 27327951)
174. Politi, L.E.; Rotstein, N.P.; Carri, N.G. Effect of GDNF on neuroblast proliferation and photoreceptor survival: additive protection with docosahexaenoic acid. Invest. Ophthalmol. Vis. Sci., 2001, 42, 3008-3015
175. Rotstein, N.P.; Politi, L.E.; Aveldaño, M.I. Docosahexaenoic acid promotes differentiation of developing photoreceptors in culture. Invest. Ophthalmol. Vis. Sci., 1998, 39, 2750-2758
176. Mares-Perlman, J.A.; Brady, W.E.; Klein, R.; VandenLangenberg, G.M.; Klein, B.E.; Palta, M. Dietary fat and age-related maculopathy. Arch. Ophthalmol., 1995, 113, 743-748
177. Smith, W.; Mitchell, P.; Leeder, S.R. Dietary fat and fish intake and age-related maculopathy. Arch. Ophthalmol., 2000, 118, 401-404 (Pubitemid 30152382)
178. Cho, E.; Hung, S.; Willett, W.C.; Spiegelman, D.; Rimm, E.B.; Seddon, J.M.; Colditz, G.A.; Hankinson, S.E. Prospective study of dietary fat and the risk of age-related macular degeneration. Am. J. Clin. Nutr., 2001, 73, 209-218 (Pubitemid 32109848)
179. Seddon, J.M.; Rosner, B.; Sperduto, R.D.; Yannuzzi, L.; Haller, J.A.; Blair, N.P.; Willett, W. Dietary fat and risk for advanced age-related macular degeneration. Arch. Ophthalmol., 2001, 119, 1191-1199 (Pubitemid 32730008)
180. Seddon, J.M.; Cote, J.; Rosner, B. Progression of age-related macular degeneration: association with dietary fat, transunsaturated fat, nuts, and fish intake. Arch. Ophthalmol., 2003, 121, 1728-1737 (Pubitemid 37517440)
181. Delcourt, C.; Carrière, I.; Cristol, J.P.; Lacroux, A.; Gerber, M. Dietary fat and the risk of age-related maculopathy: the POLANUT study. Eur. J. Clin. Nutr., 2007, 61, 1341-1344 (Pubitemid 350048218)
182. Seddon, J.M.; George, S.; Rosner, B. Cigarette smoking, fish consumption, omega-3 fatty acid intake, and associations with age-related macular degeneration: the US Twin Study of Age-Related Macular Degeneration. Arch. Ophthalmol., 2006, 124, 995-1001. (Pubitemid 44036322)
183. Chua, B.; Flood, V.; Rochtchina, E.; Wang, J.J.; Smith, W.; Mitchell, P. Dietary fatty acids and the 5-year incidence of age-related maculopathy. Arch. Ophthalmol., 2006, 124, 981-986 (Pubitemid 44043098)
184. Augood, C.; Chakravarthy, U.; Young, I.; Vioque, J.; de Jong, P.T.; Bentham, G.; Rahu, M.; Seland, J.; Soubrane, G.; Tomazzoli, L.; Topouzis, F.; Vingerling, J.R.; Fletcher, A.E. Oily fish consumption, dietary docosahexaenoic acid and eicosapentaenoic acid intakes, and associations with neovascular age-related macular degeneration. Am. J. Clin. Nutr., 2008, 88, 398-406.
185. Heuberger, R.A.; Mares-Perlman, J.A.; Klein, R.; Klein, B.E.; Millen, A.E.; Palta, M. Relationship of dietary fat to age-related maculopathy in the Third National Health and Nutrition Examination Survey. Arch. Ophthalmol., 2001, 119, 1833-1838 (Pubitemid 33139616)
186. SanGiovanni, J.P.; Chew, E.Y.; Clemons, T.E.; Davis, M.D.; Ferris, F.L. 3rd; Gensler, G.R.; Urinij, N.; Lindblad, A.S.; Milton, R.C.; Seddon, J.M.; Sperduto, .R.D.; Age-Related Eye Disease Study Research Group. The relationship of dietary lipid intake and age-related macular degeneration in a case-control study: AREDS Report No. 20. Arch. Ophthalmol., 2007, 125, 671-679
187. SanGiovanni, J.P.; Agrón, E.; Clemons, T.E.; Chew, E.Y. Omega-3 long-chain polyunsaturated fatty acid intake inversely associated with 12-year progression to advanced age-related macular degeneration. Arch. Ophthalmol., 2009, 127, 110-112
188. Chong, E.W.; Kreis, A.J.; Wong, T.Y.; Simpson, J.A.; Guymer, R.H. Dietary omega-3 fatty acid and fish intake in the primary prevention of age-related macular degeneration: a systematic review and meta-analysis. Arch. Ophthalmol., 2008, 126, 826-833
189. Hodge, W.G.; Barnes, D.; Schachter, H.M.; Pan, Y.I.; Lowcock, E.C.; Zhang, L.; Sampson, M.; Morrison, A.; Tran, K.; Miguelez, M.; Lewin, G. Evidence for the effect of omega-3 fatty acids on progression of age-related macular degeneration: a systematic review. Retina, 2007, 27, 216-221 (Pubitemid 46245650)
190. Age-Related Eye Disease Study2 (AREDS2). A multi-center, randomized trial of lutein, zeaxanthin, and long-chain omega-3 fatty acids (Docosahexaenoic Acid[DHA] and Eicosapentaenoic Acid[EPA]) in age-related Macular Degeneration. http://www.areds2.org.
191. Connor, K.M.; SanGiovanni, J.P.; Lofqvist, C.; Aderman, C.M.; Chen, J.; Higuchi, A.; Hong, S.; Pravda, E.A.; Majchrzak, S.; Carper, D.; Hellstrom, A.; Kang, J.X.; Chew, E.Y.; Salem, N. Jr.; Serhan, C.N.; Smith, L.E. Increased dietary intake of omega-3-polyunsaturated fatty acids reduces pathological retinal angiogenesis. Nat. Med., 2007, 13, 868-873
192. Koto, T.; Nagai, N.; Mochimaru, H.; Kurihara, T.; Izumi-Nagai, K.; Satofuka, S.; Shinoda, H.; Noda, K.; Ozawa, Y.; Inoue, M.; Tsubota, K.; Oike, Y.; Ishida, S. Eicosapentaenoic acid is antiinflammatory in preventing choroidal neovascularization in mice. Invest. Ophthalmol. Vis. Sci., 2007, 48, 4328-4334 (Pubitemid 351261066)
193. Grossniklaus, H.E.; Ling, J.X.; Wallace, T.M.; Dithmar, S.; Lawson, D.H.; Cohen, C.; Elner, V.M.; Elner, S.G.; Sternberg, P. Jr. Macrophage and retinal pigment epithelium expression of angiogenic cytokines in choroidal neovascularization. Mol. Vis., 2002, 8, 119-126
194. Sakurai, E.; Anand, A.; Ambati, B.K.; van Rooijen, N.; Ambati, J. Macrophage depletion inhibits experimental choroidal neovascularization. Invest. Ophthalmol. Vis. Sci., 2003, 44, 3578-3585 (Pubitemid 36909798)
195. Espinosa-Heidmann, D.G.; Suner, I.J.; Hernandez, E.P.; Monroy, D.; Csaky, K.G.; Cousins, S.W. Macrophage depletion diminishes lesion size and severity in experimental choroidal neovascularization. Invest. Ophthalmol. Vis. Sci., 2003, 44, 3586-3592
196. Tsutsumi, C.; Sonoda, K.H.; Egashira, K.; Qiao, H.; Hisatomi, T.; Nakao, S.; Ishibashi, M.; Charo, I.F.; Sakamoto, T.; Murata, T.; Ishibashi, T. The critical role of ocular-infiltrating macrophages in the development of choroidal neovascularization. J. Leukoc. Biol., 2003, 74, 25-32. (Pubitemid 38040433)
197. Rakic, J.M.; Lambert, V.; Devy, L.; Luttun, A.; Carmeliet, P.; Claes, C.; Nguyen, L.; Foidart, J.M.; Noël, A.; Munaut, C. Placental growth factor, a member of the VEGF family, contributes to the development of choroidal neovascularization. Invest. Ophthalmol. Vis. Sci., 2003, 44, 3186-3193 (Pubitemid 36759791)
198. Oh, H.; Takagi, H.; Takagi, C.; Suzuma, K.; Otani, A.; Ishida, K.; Matsumura, M.; Ogura, Y.; Honda, Y. The potential angiogenic role of macrophages in the formation of choroidal neovascular membranes. Invest. Ophthalmol. Vis. Sci., 1999, 40, 1891-1898 (Pubitemid 29365148)
199. Amin, R.; Puklin, J.E.; Frank, R.N. Growth factor localization in choroidal neovascular membranes of age-related macular degeneration. Invest. Ophthalmol. Vis. Sci., 1994, 35, 3178-3188 (Pubitemid 24241356)
200. Miyamoto, K.; Khosrof, S.; Bursell, S.E.; Moromizato, Y.; Aiello, L.P.; Ogura, Y.; Adamis, A.P. Vascular endothelial growth factor (VEGF)-induced retinal vascular permeability is mediated by intercellular adhesion molecule-1 (ICAM-1). Am. J. Pathol., 2000, 156, 1733-1739
201. Ishida, S.; Usui, T.; Yamashiro, K.; Kaji, Y.; Ahmed, E.; Carrasquillo, K.G.; Amano, S.; Hida, T.; Oguchi, Y.; Adamis, A.P. VEGF164 is proinflammatory in the diabetic retina. Invest. Ophthalmol. Vis. Sci., 2003, 44, 2155-2162
202. Simons, K.; Ikonen, E. Functional rafts in cell membranes. Nature, 1997, 387, 569-572
203. Chapkin, R.S.; McMurray, D.N.; Davidson, L.A.; Patil, B.S.; Fan, Y.Y.; Lupton, J.R. Bioactive dietary long-chain fatty acids: emerging mechanisms of action. Br. J. Nutr., 2008, 100, 1152-1157
204. Treen, M.; Uauy, R.D.; Jameson, D.M.; Thomas, V.L.; Hoffman, D.R. Effect of docosahexaenoic acid on membrane fluidity and function in intact cultured Y-79 retinoblastoma cells. Arch. Biochem. Biophys., 1992, 294, 564-570
205. Meuillet, E.J.; Leray, V.; Hubert, P.; Leray, C.; Cremel, G. Incorporation of exogenous lipids modulates insulin signaling in the hepatoma cell line, HepG2. Biochim. Biophys. Acta, 1999, 1454, 38-48. (Pubitemid 29238096)
206. Valentine, R.C.; Valentine, D.L. Omega-3 fatty acids in cellular membranes: a unified concept. Prog. Lipid Res., 2004, 43, 383-402.
207. Calviello, G.; Serini, S.; Piccioni, E. n-3 polyunsaturated fatty acids and the prevention of colorectal cancer: molecular mechanisms involved. Curr. Med. Chem., 2007, 14, 3059-3069
208. Suzuki, I.; Iigo, M.; Ishikawa, C.; Kuhara, T.; Asamoto, M.; Kunimoto, T.; Moore, M.A.; Yazawa, K.; Araki, E.; Tsuda, H. Inhibitory effects of oleic and docosahexaenoic acids on lung metastasis by colon-carcinoma-26 cells are associated with reduced matrix metalloproteinase-2 and -9 activities. Int. J. Cancer, 1997, 73, 607-612 (Pubitemid 28005328)
209. McCabe, A.J.; Wallace, J.M.; Gilmore, W.S.; McGlynn, H.; Strain, S.J. Docosahexaenoic acid reduces in vitro invasion of renal cell carcinoma by elevated levels of tissue inhibitor of metalloproteinase-1. J. Nutr. Biochem., 2005, 16, 17-22.
210. Hansen, R.A.; Harris, M.A.; Pluhar, G.E.; Motta, T.; Brevard, S.; Ogilvie, G.K.; Fettman, M.J.; Allen, K.G. Fish oil decreases matrix metalloproteinases in knee synovia of dogs with inflammatory joint disease. J. Nutr. Biochem., 2008, 19, 101-108
211. Delbosc, S.; Glorian, M.; Le Port, A.S.; Béréziat, G.; Andréani, M.; Limon, I. The benefit of docosahexanoic acid on the migration of vascular smooth muscle cells is partially dependent on Notch regulation of MMP-2/-9. Am. J. Pathol., 2008, 172, 1430-1440 (Pubitemid 351671555)
212. Priante, G.; Musacchio, E.; Valvason, C.; Baggio, B. EPA and DHA suppress AngII- and arachidonic acid-induced expression of profibrotic genes in human mesangial cells. J. Nephrol., 2009, 22, 137-143
213. Denys, A.; Hichami, A.; Khan, N.A. n-3 PUFAs modulate T-cell activation via protein kinase C-alpha and -epsilon and the NF-kappaB signaling pathway. J. Lipid Res., 2005, 46, 752-758
214. DeGraffenried, L.A.; Friedrichs, W.E.; Fulcher, L.; Fernandes, G.; Silva, J.M.; Peralba, J.M.; Hidalgo, M. Eicosapentaenoic acid restores tamoxifen sensitivity in breast cancer cells with high Akt activity. Ann. Oncol., 2003, 14, 1051-1056 (Pubitemid 36950169)
215. Kunnumakkara, A.B.; Anand, P.; Aggarwal, B.B. Curcumin inhibits proliferation, invasion, angiogenesis and metastasis of different cancers through interaction with multiple cell signaling proteins. Cancer Lett., 2008, 269, 199-225.
216. Vogelstein, B.; Kinzler, K.W. Cancer genes and the pathways they control. Nat. Med., 2004, 10, 789-799
217. rd; Gensler, G.; Lindblad, A.S.; Milton, R.C.; Seddon, J.M.; Klein, R.; Sperduto, R.D.; Age-Related Eye Disease Study Research Group. The relationship of dietary omega-3 long-chain polyunsaturated fatty acid intake with incident age-related macular degeneration: AREDS report no. 23. Arch. Ophthalmol., 2008, 126, 1274-1279